Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.

NCT03281187 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypogonadism

Interventions

DRUG: Nasotestt 5 mg
DRUG: Androgel 50 mg
OTHER: Nasotestt Placebo
OTHER: Androgel Placebo

Sponsor

FBM Industria Brasileira Ltda

Collaborators

[object Object]